Maria C. Carraro

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

The 2024 Three-Strata Baseline Anemia Definition of the Revised IWG-ELN Criteria Dissects Survival in Ruxolitinib-Treated Myelofibrosis Patients.

The 2024 Three-Strata Baseline Anemia Definition of the Revised IWG-ELN Criteria Dissects Survival in Ruxolitinib-Treated Myelofibrosis Patients.

Journal: American journal of hematology

Published: March 05, 2025

Real-World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi-Resistant Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Patient Population.

Real-World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi-Resistant Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Patient Population.

Journal: Hematological oncology

Published: February 14, 2025

Bone Marrow CD34+/lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects.

Bone Marrow CD34+/lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects.

Journal: Cancers

Published: February 13, 2025

Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implications.

Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implications.

Journal: Hematological oncology

Published: August 09, 2024

Bosutinib Treatment of Chronic Myeloid Leukemia in Lombardy.

Bosutinib Treatment of Chronic Myeloid Leukemia in Lombardy.

Journal: Acta haematologica

Published: April 28, 2024

A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis.

A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis.

Journal: Blood advances

Published: December 21, 2021

Nilotinib-induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study.

Nilotinib-induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study.

Journal: European journal of haematology

Published: March 05, 2021

Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in Asthma Secondary to Chronic Myeloid Leukemia with Hypereosinophilia.

Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in Asthma Secondary to Chronic Myeloid Leukemia with Hypereosinophilia.

Journal: Anti-inflammatory & anti-allergy agents in medicinal chemistry

Published: March 01, 2021

Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study.

Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study.

Journal: Blood research

Published: June 05, 2020

Unexpected Neurological Symptoms of Ruxolitinib: A Case Report.

Unexpected Neurological Symptoms of Ruxolitinib: A Case Report.

Journal: Journal of hematology

Published: April 21, 2020

Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients.

Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients.

Journal: Blood advances

Published: July 01, 2019

Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study).

Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study).

Journal: British journal of haematology

Published: May 21, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026